Back to Search
ALBERTO CHIAPPORI MD
MD
Medical Oncology Physician
NPI: 1952331654IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
ME86895(FL)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
ME86895(FL)
Education
OTHER
Class of 1989
Research & Publications (20)
Phase I/II study of atrasentan, an endothelin A receptor antagonist, in combination with paclitaxel and carboplatin as first-line therapy in advanced non-small cell lung cancer.
PMID 18316570·Clin Cancer Res·2008
3-trial
A phase I pharmacokinetic and pharmacodynamic study of s-3304, a novel matrix metalloproteinase inhibitor, in patients with advanced and refractory solid tumors.
PMID 17404091·Clin Cancer Res·2007
3-trial
A phase I evaluation of oral CI-1033 in combination with paclitaxel and carboplatin as first-line chemotherapy in patients with advanced non-small cell lung cancer.
PMID 17409987·J Thorac Oncol·2006
3-trial
Phase II study of first-line sequential chemotherapy with gemcitabine-carboplatin followed by docetaxel in patients with advanced non-small cell lung cancer.
PMID 16020967·Oncology·2005
3-trial
New agents in the treatment of small-cell lung cancer: focus on gemcitabine.
PMID 14720338·Clin Lung Cancer·2003
8-other
A randomized phase 2 study of erlotinib alone and in combination with bortezomib in previously treated advanced non-small cell lung cancer.
PMID 19633475·J Thorac Oncol·2009
3-trial
A functional soluble form of CTLA-4 is present in the serum of celiac patients and correlates with mucosal injury.
PMID 19625381·Int Immunol·2009
8-other
Serum cytotoxic T lymphocyte-associated antigen 4 in Hymenoptera venom allergy and its modulation by specific immunotherapy.
PMID 18926563·J Allergy Clin Immunol·2009
7-preclinical
Phase 2 trial of docetaxel and gefitinib in the first-line treatment of patients with advanced nonsmall-cell lung cancer (NSCLC) who are 70 years of age or older.
PMID 18300255·Cancer·2008
3-trial
Cardiac toxicity: old and new issues in anti-cancer drugs.
PMID 18208791·Clin Transl Oncol·2008
6-review
Increased cyclin D3 expression significantly correlates with p27 nuclear positivity in gastrointestinal stromal tumors.
PMID 18701138·Hum Pathol·2008
8-other
Clinical efficacy and predictive molecular markers of neoadjuvant gemcitabine and pemetrexed in resectable non-small cell lung cancer.
PMID 18827606·J Thorac Oncol·2008
3-trial
Prevalence of post-partum thyroiditis in Liguria (Italy): an observational study.
PMID 19246971·J Endocrinol Invest·2008
8-other
Soluble CTLA-4 in autoimmune thyroid diseases: relationship with clinical status and possible role in the immune response dysregulation.
PMID 17321799·Clin Immunol·2007
8-other
Multicenter, randomized, phase II trial of CI-1033, an irreversible pan-ERBB inhibitor, for previously treated advanced non small-cell lung cancer.
PMID 17761977·J Clin Oncol·2007
3-trial
Phase I trial of poly-L-glutamate camptothecin (CT-2106) administered weekly in patients with advanced solid malignancies.
PMID 17908979·Clin Cancer Res·2007
3-trial
Phase I trial of histone deacetylase inhibition by valproic acid followed by the topoisomerase II inhibitor epirubicin in advanced solid tumors: a clinical and translational study.
PMID 17513804·J Clin Oncol·2007
3-trial
Phase I study of carboplatin in combination with gemcitabine and irinotecan in patients with solid tumors: preliminary evidence of activity in small cell and neuroendocrine carcinomas.
PMID 17326096·Cancer·2007
3-trial
Feasibility and efficacy of molecular analysis-directed individualized therapy in advanced non-small-cell lung cancer.
PMID 17602079·J Clin Oncol·2007
3-trial
Phase I study of the taxane BMS-188797 in combination with carboplatin administered every 3 weeks in patients with solid malignancies.
PMID 16428495·Clin Cancer Res·2006
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 12902 USF MAGNOLIA DR, MDC 44
TAMPA, FL 33612 - Phone
- (813) 745-3980
Quick Facts
- NPI
- 1952331654
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 37
- Publications
- 20
Are you this provider?
Claim Your Profile